Many AD changes other than amyloid and tau pathology have been reported in these mouse models (APOE4/5xFAD or APOE4/PS19) such as dysfunction in lipid metabolism and immune systems, highlighting the importance of incorporating APOE4 genotype into the studies of AD pathological processes. This evidence concerns the gene APOE and Alzheimer disease.